|
METTL4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
1.094170E-01 |
| Stage1-vs-Stage3 |
1.098420E-02 |
| Stage1-vs-Stage4 |
1.592430E-04 |
| Stage2-vs-Stage3 |
7.938200E-01 |
| Stage2-vs-Stage4 |
1.152170E-01 |
| Stage3-vs-Stage4 |
1.179150E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.80702153030188E-12 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
6.689200E-01 |
| Caucasian-vs-Asian |
3.819600E-01 |
| AfricanAmerican-vs-Asian |
8.481200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.400200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.76350999999686E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.580100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.823500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.381000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.753800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.928000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.174800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.757200E-04 |
| Classical-VS-Follicular |
5.311800E-01 |
| Classical-VS-Other |
4.720000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.205000E-04 |
| Tall-VS-Other |
2.681000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.575800E-01 |
| Follicular-VS-Normal |
1.62458935193399E-12 |
| Other-VS-Normal |
1.48180000003606E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.782560E-01 |
|
|
